Canada markets open in 7 hours 58 minutes

Calidi Biotherapeutics, Inc. (CLDI)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.2420+0.0084 (+3.60%)
At close: 04:00PM EDT
0.2350 -0.01 (-2.89%)
After hours: 07:37PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
45
449
0
Cost of Revenue
0
0
14
94
0
Gross Profit
0
0
31
355
0
Operating Expenses
Research Development
13,008
13,008
7,257
4,674
3,182
Selling General and Administrative
15,984
15,984
15,902
6,163
3,591
Total Operating Expenses
26,107
26,107
23,159
10,837
6,773
Operating Income or Loss
-26,107
-26,107
-23,128
-10,482
-6,773
Interest Expense
1,069
1,069
158
614
163
Total Other Income/Expenses Net
656
656
-2,130
174
-997
Income Before Tax
-29,200
-29,200
-25,416
-10,922
-7,933
Income Tax Expense
16
16
11
11
4
Income from Continuing Operations
-29,216
-29,216
-25,427
-10,933
-7,937
Net Income
-29,216
-29,216
-25,427
-10,933
-7,937
Net Income available to common shareholders
-29,216
-29,216
-25,427
-10,933
-7,937
Basic EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Diluted EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Basic Average Shares
35,907
16,887
35,907
35,907
35,907
Diluted Average Shares
35,907
16,887
35,907
35,907
35,907